ENSEM Therapeutics
Signal active
Organization
Contact Information
Overview
ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.
About
Industries
Biotechnology, Therapeutics, Oncology
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ENSEM Therapeutics headquartered in United States, North America, operates in the Biotechnology, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $1.8B in funding across 24 round(s). With a team of 11-50 employees, ENSEM Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - ENSEM Therapeutics, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
3
Lead Investors
0
Total Funding Amount
$77.0M
Details
2
ENSEM Therapeutics has raised a total of $77.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 67.0M | ||
| 2023 | Early Stage Venture | 10.0M |
Investors
ENSEM Therapeutics is funded by 17 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Zhao Gong | - | FUNDING ROUND - Zhao Gong | 10.0M |
| Boquan Capital | - | FUNDING ROUND - Boquan Capital | 10.0M |
| Huang Yuqing | - | FUNDING ROUND - Huang Yuqing | 10.0M |
| ENSEM Therapeutics | - | FUNDING ROUND - ENSEM Therapeutics | 10.0M |
Recent Activity
There is no recent news or activity for this profile.